Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can someone tell me how many months did it
take for the F**king Degenerate Assholes (FDA)
to approve IPCI's 15 mg and 30 mg Focalin?
Thanks jbem.
TNXP - bought back @7.25. This is now 18% lower
than what i sold it for two weeks ago.
200 day MA is @7.04, so very close to a major
support level. The stock is close to being
oversold with RSI @35 and stochastics are in
a buying zone.
SLGD - bought @.96. RSI and stochastics are
low and MACD flattening with the stock down
from 1.49 high after posting .06 in Q1.
With earnings of .19 in the last 12 months and
around .50 a share in cash, this one looks cheap.
Hopefully they will post at least .04 for Q2.
PESI - sold @3.75 - 3.78. They posted EPS
of .05 from continued operations and bottom
line was a loss of .01
Q2 was weaker than expected because of this:
"Our second quarter results were impacted by a
scheduling change that moved a large shipment
into the third quarter, which we have
subsequently received."
So Q3 should be very good but i prefer investing
my money elsewhere and buy again before Q3 results.
http://finance.yahoo.com/news/perma-fix-announces-financial-results-113000183.html
It is always wise to take profits so
i sold this morning @2.66 for a double #msg-115960216
but still holding free shares since still to come soon
are the results of the Markman Hearings in the Proofpoint
case and the Symantec case.
As i said yesterday (and my timing was
unfortunately impecabble), the FDA is a corrupt
and incompetent organization.
I will say it again: How much more sh!t will small companies
and investors have to eat before something is being done?
>>the FDA stated "Upon review, we have concluded that our rescission was issued in error."<<
Seriously? They should sue those mofos.
Thanks hweb!
FNJN - sold some @2.66 for a double.
FNJN - Ruling in Favor of Finjan for Nearly $40 Million as Blue Coat Trial Concludes
Jury Finds Five of Six Finjan's Patents Infringed by Blue Coat Systems
EAST PALO ALTO, CA--(Marketwired - Aug 5, 2015) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, announced today that the jury in Finjan, Inc. v. Blue Coat Systems Inc. (5:13-cv-03999-BLF) returned a unanimous verdict that Finjan's U.S. Patent Nos. 6,154,844 (the "'844 Patent"), 6,804,780 (the "'780 Patent"), 6,965,968 (the "'968 Patent"), and the 7,418,731 (the "'731 Patent") were literally infringed by Blue Coat. Further, the jury found that U.S. Patent No. 7,647,633 (the "'633 Patent") was infringed by Blue Coat under the Doctrine of Equivalents. Moreover, the jury found each of Finjan's asserted patents valid. The verdict, reached on August 04, 2015, followed a two-week trial before the Honorable Beth Labson Freeman of the U.S. District Court for the Northern District of California.
Finjan alleged that Blue Coat's products or combination of products, namely, WebPulse, ProxySG, CAS (or Content Analysis System), MAA (or Malware Analysis Appliance), and ProxyAG infringed one or more of the asserted claims of the asserted patents.
The jury also decided that Finjan was entitled to $39,528,487.00 damages as reasonable royalties for Blue Coat's infringement.
"We are both grateful and gratified with the jury's verdict," said Julie Mar-Spinola, Finjan's Chief Intellectual Property Officer and VP, Legal. "As we have stated in our earlier Litigation Updates, we are committed to our licensing best practices and will present our patent infringement claims credibly and convincingly to establish the merits of our case, in and outside of the courtroom. Additionally, we were confident in the merits of our patent claims against Blue Coat. It is significant that the jury unanimously agreed with us on all but one."
Finjan is well-represented by Paul Andre, Lisa Kobialka, James Hannah, Hannah Lee, and Kris Kastens, and many other significant contributors from the law offices of Kramer Levin Naftalis & Frankel in Menlo Park, CA.
Finjan has also filed a second patent infringement lawsuit against Blue Coat Systems, Inc. (Blue Coat), alleging infringement of seven Finjan patents relating to new infringing Blue Coat products and services. The Complaint (5:15-cv-03295, Docket No. 1), filed July 15, 2015, in the U.S. District Court for the Northern District of California, alleges that Blue Coat's new products and services infringe seven Finjan patents. In particular, Finjan is asserting infringement of U.S. Patent Nos. 6,154,844; 6,965,968; 7,418,731; 8,079,086; 8,225,408; 8,566,580; 8,677,494; four of which are being asserted against Blue Coat for the first time. This matter has also been assigned to Judge Freeman.
Finjan has filed patent infringement lawsuits against FireEye, Proofpoint, Sophos, Symantec, and Palo Alto Networks relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
ABOUT FINJAN
Established nearly 20 years ago, Finjan is a globally recognized leader in cybersecurity. Finjan's inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, please visit www.finjan.com.
http://finance.yahoo.com/news/ruling-favor-finjan-nearly-40-123000456.html
Ruling in Favor of Finjan for Nearly $40 Million as Blue Coat Trial Concludes
Jury Finds Five of Six Finjan's Patents Infringed by Blue Coat Systems
EAST PALO ALTO, CA--(Marketwired - Aug 5, 2015) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, announced today that the jury in Finjan, Inc. v. Blue Coat Systems Inc. (5:13-cv-03999-BLF) returned a unanimous verdict that Finjan's U.S. Patent Nos. 6,154,844 (the "'844 Patent"), 6,804,780 (the "'780 Patent"), 6,965,968 (the "'968 Patent"), and the 7,418,731 (the "'731 Patent") were literally infringed by Blue Coat. Further, the jury found that U.S. Patent No. 7,647,633 (the "'633 Patent") was infringed by Blue Coat under the Doctrine of Equivalents. Moreover, the jury found each of Finjan's asserted patents valid. The verdict, reached on August 04, 2015, followed a two-week trial before the Honorable Beth Labson Freeman of the U.S. District Court for the Northern District of California.
Finjan alleged that Blue Coat's products or combination of products, namely, WebPulse, ProxySG, CAS (or Content Analysis System), MAA (or Malware Analysis Appliance), and ProxyAG infringed one or more of the asserted claims of the asserted patents.
The jury also decided that Finjan was entitled to $39,528,487.00 damages as reasonable royalties for Blue Coat's infringement.
"We are both grateful and gratified with the jury's verdict," said Julie Mar-Spinola, Finjan's Chief Intellectual Property Officer and VP, Legal. "As we have stated in our earlier Litigation Updates, we are committed to our licensing best practices and will present our patent infringement claims credibly and convincingly to establish the merits of our case, in and outside of the courtroom. Additionally, we were confident in the merits of our patent claims against Blue Coat. It is significant that the jury unanimously agreed with us on all but one."
Finjan is well-represented by Paul Andre, Lisa Kobialka, James Hannah, Hannah Lee, and Kris Kastens, and many other significant contributors from the law offices of Kramer Levin Naftalis & Frankel in Menlo Park, CA.
Finjan has also filed a second patent infringement lawsuit against Blue Coat Systems, Inc. (Blue Coat), alleging infringement of seven Finjan patents relating to new infringing Blue Coat products and services. The Complaint (5:15-cv-03295, Docket No. 1), filed July 15, 2015, in the U.S. District Court for the Northern District of California, alleges that Blue Coat's new products and services infringe seven Finjan patents. In particular, Finjan is asserting infringement of U.S. Patent Nos. 6,154,844; 6,965,968; 7,418,731; 8,079,086; 8,225,408; 8,566,580; 8,677,494; four of which are being asserted against Blue Coat for the first time. This matter has also been assigned to Judge Freeman.
Finjan has filed patent infringement lawsuits against FireEye, Proofpoint, Sophos, Symantec, and Palo Alto Networks relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
ABOUT FINJAN
Established nearly 20 years ago, Finjan is a globally recognized leader in cybersecurity. Finjan's inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, please visit www.finjan.com.
http://finance.yahoo.com/news/ruling-favor-finjan-nearly-40-123000456.html
FNJN (1.61) - have been climbing gradually and is
up 21% in 2 months. While there aren't any news yet
from the company, from reading other threads it seems
like they were awarded approx $40 million by the jury
in the "Blue Coat" trial.
FNJN's market cap is a little less than $40 million.
Still to come soon are the results of the Markman
Hearings in the Proofpoint case and the Symantec case.
The Markman hearing is an important pre-trial event in a patent lawsuit, wherein the Court will interpret certain disputed claim terms (aka claim elements) in the asserted Finjan patent claims, after consideration of the parties' evidence. As previously reported in its suits against Blue Coat Systems and Sophos Ltd., Finjan has received favorable claim constructions in support of their infringement assertions in those matters.
I wonder what the F**k needs to happen
for the incompetent FDA to start doing
their F**king job.
How much more sh!t will small companies and investors
have to eat before something is being done?
Almost a month has passed since the FDA fools
rescinded the previous requirement that the Company meet
newly imposed conditions for bioequivalence prior to
receiving final approval for the tentatively approved
strengths of its generic Focalin XR, yet they still
haven't approved it.
And i am not even talking about the other generic drugs
in the pipeline that are way due for an approval.
This FDA incompetency is truly unbelievable.
PESI - will report on Thursday. I added @3.6
in the last few days. Now back to being one of my
largest holdings.
This report should be a big improvement VS Q2 a year ago.
Looking at the chart, stochastics are in a buying
zone and MACD is starting to flatten.
http://finance.yahoo.com/news/perma-fix-schedules-second-quarter-144428659.html
Perma-Fix Schedules Second Quarter 2015 Earnings Conference Call
Marketwired Perma-Fix Environmental Services, Inc.
ATLANTA, GA--(Marketwired - August 04, 2015) - Perma-Fix Environmental Services, Inc. (PESI) today announced that it will host a conference call at 11:00 a.m. ET on Thursday, August 6, 2015. The call will be available on the Company's website at www.perma-fix.com, or by calling 877-407-0778 for U.S. callers, or +1-201-689-8565 for international callers. The conference call will be led by Dr. Louis F. Centofanti, Chief Executive Officer, and Ben Naccarato, Vice President and Chief Financial Officer, of Perma-Fix Environmental Services, Inc.
A webcast will also be archived on the Company's website and a telephone replay of the call will be available approximately one hour following the call, through midnight September 6, 2015, and can be accessed by calling: 877-660-6853 (U.S. callers) or +1-201-612-7415 (international callers) and entering conference ID: 13616885.
SCKT - posts .07 for Q2:
Socket Mobile Reports Profitable Second Quarter and Six Months Results
Second Quarter Net Income of $401,000 up 332% Year Over Year
PR Newswire Socket Mobile, Inc.
NEWARK, Calif., July 29, 2015 /PRNewswire/ -- Socket Mobile, Inc. (SCKT), an innovative provider of mobile barcode scanning products, today reported financial results for its 2015 second quarter and six month period ended June 30, 2015.
Revenue for the second quarter of 2015 was $4.5 million, an increase of 2 percent from revenue of $4.4 million for the same quarter a year ago and an increase of 12 percent sequentially from revenue of $4.0 million in the immediately preceding quarter. Net income for the second quarter of 2015 was $401,000, or $0.07 per share, compared to net income of $93,000, or $0.02 per share, in the second quarter of 2014, and a net loss of $72,000, or $0.01 per share, in the immediately preceding quarter. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA), a non-GAAP measure of operating results, was $588,000, or $0.11 per share, in the second quarter of 2015, compared to $413,000, or $0.08 per share, in the second quarter of 2014 and $108,000, or $0.02 per share, in the immediately preceding quarter.
Revenue for the six months ended June 30, 2015 was $8.5 million, an increase of 4 percent from revenue of $8.2 million in the same period a year ago. Net income for the six months ended June 30, 2015 was $329,000, or $0.06 per share, compared to net income of $21,000, or $0.00 per share, for the same period a year ago. Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) for the six months ended June 30, 2015 was $696,000, or $0.13 per share, compared to net EBITDA earnings of $617,000, or $0.13 per share, for the same period a year ago.
Operating expenses for the second quarter of 2015 were $1.6 million, flat compared to operating expenses of $1.6 million for the same quarter a year ago, and a decrease of 10 percent sequentially from the immediately preceding quarter. Operating expenses for the six months ended June 30, 2015 were $3.4 million, an increase of 8 percent compared to operating expenses of $3.2 million for the same period a year ago.
Kevin Mills, president and chief executive officer, commented, "On a year-over-year basis, our second quarter results reflect increased revenue, improved margins, flat operating expenses, and a more than fourfold increase in net income. These results reflect growing demand for our cordless barcode scanners for mobile point of sale and other mobile applications marketed by our growing community of registered application developers.
"In the second quarter, our cordless barcode scanner revenue comprised 88 percent of total quarterly revenue and reached a record $3,947,000, up from $3,686,000 in the same quarter a year ago. This record barcode scanner revenue in the second quarter included two larger deployments totaling $400,000, compared to the prior year quarter which included three larger deployments totaling $900,000. When these larger deployments are factored out, the underlying growth run rate in our cordless barcode scanner sales was 27 percent year over year.
"We believe 2015 should be a year of growth for Socket Mobile, primarily driven by mobile point of sale as well as an expanding Socket Mobile product portfolio and maturing mobile markets. We believe we are well positioned in our targeted markets and remain focused on increasing our profitability and building the business for further growth in 2016," Mills concluded.
Conference Call
Management of Socket will hold a conference call and web cast today at 2 P.M. PT to discuss the quarterly results and outlook for the future. The dial-in number to access the call is (877) 407-9210 from within the U.S. or (201) 689-8049 from international locations. A replay will be available via telephone for a week following the call at (877) 660-6853 from within the U.S., or (201) 612-7415 from international locations. The conference ID is 13612963#. The call will also be carried live and available via replay through a link on Socket's website at www.socketmobile.com. From the home page, choose "About Socket"/"Investor Relations"/"Conference Calls and Events." A transcript will be posted on the Company's website within a few days of the call.
About Socket Mobile Founded in 1992, Socket Mobile is a leading innovator of data capture solutions for enhanced productivity in retail point of sale, field service, healthcare, and other mobile markets. Socket Mobile's portfolio includes cordless handheld barcode scanners for tablets and smartphones. Socket Mobile's revenue is primarily driven by 3rd party developer deployment of barcode enabled mobile applications. Socket Mobile has a robust network of over 1,400 registered developers using its software developer kit to tightly integrate and enable sophisticated barcode scanning into their applications. Socket Mobile is headquartered in Newark, Calif. and can be reached at +1-510-933-3000 or www.socketmobile.com. Follow Socket Mobile on Facebook, Twitter @socketmobile or subscribe to sockettalk, the company's official blog.
http://finance.yahoo.com/news/socket-mobile-reports-profitable-second-200100339.html
SCKT - posts .07 for Q2:
Socket Mobile Reports Profitable Second Quarter and Six Months Results
Second Quarter Net Income of $401,000 up 332% Year Over Year
PR Newswire Socket Mobile, Inc.
NEWARK, Calif., July 29, 2015 /PRNewswire/ -- Socket Mobile, Inc. (SCKT), an innovative provider of mobile barcode scanning products, today reported financial results for its 2015 second quarter and six month period ended June 30, 2015.
Revenue for the second quarter of 2015 was $4.5 million, an increase of 2 percent from revenue of $4.4 million for the same quarter a year ago and an increase of 12 percent sequentially from revenue of $4.0 million in the immediately preceding quarter. Net income for the second quarter of 2015 was $401,000, or $0.07 per share, compared to net income of $93,000, or $0.02 per share, in the second quarter of 2014, and a net loss of $72,000, or $0.01 per share, in the immediately preceding quarter. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA), a non-GAAP measure of operating results, was $588,000, or $0.11 per share, in the second quarter of 2015, compared to $413,000, or $0.08 per share, in the second quarter of 2014 and $108,000, or $0.02 per share, in the immediately preceding quarter.
Revenue for the six months ended June 30, 2015 was $8.5 million, an increase of 4 percent from revenue of $8.2 million in the same period a year ago. Net income for the six months ended June 30, 2015 was $329,000, or $0.06 per share, compared to net income of $21,000, or $0.00 per share, for the same period a year ago. Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) for the six months ended June 30, 2015 was $696,000, or $0.13 per share, compared to net EBITDA earnings of $617,000, or $0.13 per share, for the same period a year ago.
Operating expenses for the second quarter of 2015 were $1.6 million, flat compared to operating expenses of $1.6 million for the same quarter a year ago, and a decrease of 10 percent sequentially from the immediately preceding quarter. Operating expenses for the six months ended June 30, 2015 were $3.4 million, an increase of 8 percent compared to operating expenses of $3.2 million for the same period a year ago.
Kevin Mills, president and chief executive officer, commented, "On a year-over-year basis, our second quarter results reflect increased revenue, improved margins, flat operating expenses, and a more than fourfold increase in net income. These results reflect growing demand for our cordless barcode scanners for mobile point of sale and other mobile applications marketed by our growing community of registered application developers.
"In the second quarter, our cordless barcode scanner revenue comprised 88 percent of total quarterly revenue and reached a record $3,947,000, up from $3,686,000 in the same quarter a year ago. This record barcode scanner revenue in the second quarter included two larger deployments totaling $400,000, compared to the prior year quarter which included three larger deployments totaling $900,000. When these larger deployments are factored out, the underlying growth run rate in our cordless barcode scanner sales was 27 percent year over year.
"We believe 2015 should be a year of growth for Socket Mobile, primarily driven by mobile point of sale as well as an expanding Socket Mobile product portfolio and maturing mobile markets. We believe we are well positioned in our targeted markets and remain focused on increasing our profitability and building the business for further growth in 2016," Mills concluded.
Conference Call
Management of Socket will hold a conference call and web cast today at 2 P.M. PT to discuss the quarterly results and outlook for the future. The dial-in number to access the call is (877) 407-9210 from within the U.S. or (201) 689-8049 from international locations. A replay will be available via telephone for a week following the call at (877) 660-6853 from within the U.S., or (201) 612-7415 from international locations. The conference ID is 13612963#. The call will also be carried live and available via replay through a link on Socket's website at www.socketmobile.com. From the home page, choose "About Socket"/"Investor Relations"/"Conference Calls and Events." A transcript will be posted on the Company's website within a few days of the call.
About Socket Mobile Founded in 1992, Socket Mobile is a leading innovator of data capture solutions for enhanced productivity in retail point of sale, field service, healthcare, and other mobile markets. Socket Mobile's portfolio includes cordless handheld barcode scanners for tablets and smartphones. Socket Mobile's revenue is primarily driven by 3rd party developer deployment of barcode enabled mobile applications. Socket Mobile has a robust network of over 1,400 registered developers using its software developer kit to tightly integrate and enable sophisticated barcode scanning into their applications. Socket Mobile is headquartered in Newark, Calif. and can be reached at +1-510-933-3000 or www.socketmobile.com. Follow Socket Mobile on Facebook, Twitter @socketmobile or subscribe to sockettalk, the company's official blog.
http://finance.yahoo.com/news/socket-mobile-reports-profitable-second-200100339.html
NHTC - Thanks larry. Now up to 34! Next time
i write that "RSI,MACD and stochastics
are so low that it has plenty of room to run,
especially after such a good report.",
i should just listen to myself and not sell too soon.
BTW, They barely pay any Income Tax Expense,
but 3 more Q's like this one and they will
have to start paying taxes.
NHTC - sold @30.53. Quick 24%. Thanks hweb!
NHTC - I tend to take quick profits, but RSI,
MACD and stochastics are so low that it has plenty
of room to run, especially after such a good report.
As to "I'd sell before the CC in case they say business
has slowed slightly in July."
The CEO said in the PR that "Our Hong Kong business continues
to excel, and to date, the economic slowdown in China has not impacted us"
NHTC - Thanks! i bought it 10 minutes
before the close @24.7 after seeing your post.
I looked at the chart and the stock is close to
being oversold with stochastics in a buying zone.
So with the pre-announced huge revenue quarter it
seemed like a good risk-reward.
After the close they posted EPS of 0.98!
NHTC Announces 104% Revenue Increase, 101% Net Income Increase, for Second Quarter of 2015
Record Revenue Increases to $69.7 Million While Net Income Reaches $12.3 Million; Company Increases Dividend by 33% to $0.04 Per Share, Authorizes $15 Million Share Repurchase
http://finance.yahoo.com/news/nhtc-announces-104-revenue-increase-203000124.html
PESI - Perma-Fix Announces That Its Subsidiary, Perma-Fix Medical S.A., Has Completed Its Strategic Partnership and Investment From Digirad Corporation
Marketwired Perma-Fix Environmental Services, Inc.
ATLANTA, GA--(Marketwired - July 27, 2015) - Perma-Fix Environmental Services, Inc. (PESI) today announced that its Polish subsidiary, Perma-Fix Medical, S.A., has completed its previously announced strategic partnership and investment from Digirad Corporation, one of the largest national providers of in-office nuclear cardiology imaging services. Digirad uses Technetium-99m (Tc-99m) in its nuclear imaging services business and provides imaging expertise to the medical community.
Under this partnership, Digirad invested $1 million into Perma-Fix Medical S.A., which is a publicly traded company listed on the NewConnect market of the Warsaw Stock Exchange. The investment constituted approximately 5.4% of the outstanding common shares of Perma-Fix Medical S.A. As part of the partnership and investment, Digirad appointed Matt Molchan, President and CEO of Digirad Corporation, to Perma-Fix Medical S.A.'s Supervisory Board. As part of the partnership, upon successful completion of development of the new Tc-99m resin, Digirad will purchase agreed upon quantities of Tc-99m for its nuclear imaging operations either directly or in conjunction with its preferred nuclear pharmacy supplier and Perma-Fix Medical S.A. will supply Digirad or its preferred nuclear pharmacy supplier with Tc-99m at a preferred rate.
Steve Belcher, CEO of Perma-Fix Medical S.A., commented, "We are pleased to have finalized our agreement with Digirad, which we believe will help accelerate development and commercialization of our new proprietary process to produce Tc-99m without the use of uranium. This new process does not use either highly enriched uranium (HEU) or low enriched uranium (LEU), and therefore addresses the major industry challenges of the current process, including waste production, proliferation risk, and a stable supply chain. As one of the leading users of Tc-99m, Digirad is an ideal partner with extensive industry knowledge and expertise to help finalize our development."
Dr. Centofanti, President and CEO of Perma-Fix Environmental Services, Inc. continued, "We are pleased to move forward with our strategic partnership with Digirad, especially in light of our recent tests at the 4 curie level, which confirmed that our proprietary resins could withstand higher levels of radiation. This milestone has gained significant attention within the industry and we are moving forward rapidly with plans to establish additional partners involved in the supply chain."
Matt Molchan, President and CEO of Digirad, commented, "Perma-Fix Medical S.A. has made significant progress since we began our relationship and we look forward to working closely with them to bring this transformation process to market. We believe the Perma-Fix Medical S.A. process can develop into the standard of production of Tc-99m for many years into the future."
About Tc-99m
Tc-99m is the most widely used medical isotope in the world. It allows medical practitioners to image internal body organs and is used in 80%-85% of the 25 million diagnostic nuclear medical procedures each year in the U.S. alone. Common procedures include: cardiac imaging; cancer detection; bone scans; gastrointestinal issues; imaging of the brain, kidney, spleen; and imaging for infections. The radioisotope market in Europe alone is expected to reach $1.6 billion in 2017, up from $1.1 billion in 2012.
Nearly all of the world's supply of Tc-99m comes from the thermal fission of HEU targets in a small number of highly specialized reactors. The current process is costly and from time to time, has experienced disruptions which has resulted in short-term shortages. The current process also raises serious proliferation concerns related to the threat associated with international production, transportation and/or use of HEU in the production of medical isotopes.
Perma-Fix Medical S.A.'s technology overcomes these issues by using neutron capture to activate natural molybdenum, a common metal, to produce Molybdenum 99 (Mo-99), which decays into Tc-99m. Unlike conventional processes, the Perma-Fix Medical S.A. process can be produced locally using standard research and commercial reactors, thereby eliminating the need for special purpose reactors. The new process encompasses the full production cycle, from reactor to final medical supply, and should be easily deployable around the world within the current industry infrastructure.
To overcome past issues with neutron activation of Mo-99, Perma-Fix Medical S.A. has developed a specialized resin that is radiation resistant and holds large quantities of Mo-99, but at the same time releases almost 90% of the Tc-99m as it forms from the decay of Mo-99. The resin, loaded with the activated Mo-99, is placed in a technetium generator and slowly washed with a saline based solution. The eluent solution containing Tc-99m has been shown to meet targeted United States Pharmacopeia (USP) standards for pertechnetate.
About Digirad
Digirad delivers convenient, effective, and efficient diagnostic solutions on an as needed, when needed, and where needed basis. Digirad is one of the largest national providers of in-office nuclear cardiology and ultrasound imaging services, and also provides cardiac event monitoring services. These services are provided to physician practices, hospitals and imaging centers through its Diagnostic Services business. Digirad also sells medical diagnostic imaging systems, including solid-state gamma cameras, for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products sold through its Diagnostic Imaging business. For more information, please visit www.digirad.com. Digirad® and Cardius® are registered trademarks of Digirad Corporation.
About Perma-Fix Medical S.A.
Perma-Fix Medical S.A. is a subsidiary of Perma-Fix Environmental Services Inc., a NASDAQ listed company. It was formed to develop, obtain U.S. Food and Drug Administration (FDA) and other regulatory approvals and commercialize a new process to produce Tc-99m, the most widely used medical isotope in the world. The new process is expected to solve worldwide shortages of Tc-99m as it is less expensive, does not require the use of government-subsidized, weapons-grade materials and can be easily deployed around the world using standard research and commercial reactors, thereby eliminating the need for special purpose reactors. Please visit Perma Fix Medical S.A. at http://www.medical-isotope.com.
About Perma-Fix Environmental Services
Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy (DOE), the Department of Defense (DOD), and the commercial nuclear industry. The Company's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities nationwide. Please visit Perma Fix Environmental Service at http://www.perma-fix.com.
http://finance.yahoo.com/news/perma-fix-announces-subsidiary-perma-120000466.html
MOC - i believe it will take less than a year,
but even if it takes 4-6 months, we still have time.
Since i am almost fully invested and MOC has another
tough comp coming in the June Q, i prefer buying
it down the road.
SCKT - Socket Mobile Announces 2015 Second Quarter Results Release Date and Conference Call
PR Newswire Socket Mobile, Inc.
NEWARK, Calif., July 22, 2015 /PRNewswire/ -- Socket Mobile, Inc. (SCKT), a leading innovator of data capture solutions, today announced that it will release its 2015 second quarter financial results at the closing of the market on Wednesday, July 29, 2015. The Company will also host a conference call and webcast to discuss these results that will begin at 5 p.m. Eastern Time (2 p.m. Pacific Time).
What:
Socket Mobile 2015 Second Quarter Financial Results Conference Call
When:
Wednesday, July 29, 2015 at 5 p.m. Eastern Time (2 p.m. Pacific Time)
Webcast:
A live and replay webcast of the conference call can be accessed through a link on Socket Mobiles website at www.socketmobile.com. From the home page, choose "About Us"/"Investor Relations"/"Conference Calls and Events."
Dial in:
To access the live conference call, dial (877) 407-9210 from within the U.S. or (201) 689-8049 from international locations and give the company name "Socket."
Replay:
There will be a telephone playback available for one week following the call. The replay can be accessed at (877) 660-6853 from within the U.S. or (201) 612-7415 from international locations. The conference ID is 13612963#. In addition, a transcript will be posted on the company's website within a few days of the call.
About Socket Mobile Founded in 1992, Socket Mobile is a leading innovator of data capture solutions for enhanced productivity in retail point of sale, field service, healthcare, and other mobile markets. Socket Mobile's portfolio includes cordless handheld barcode scanners for tablets and smartphones. Socket Mobile's revenue is primarily driven by 3rd party developer deployment of barcode enabled mobile applications. Socket Mobile has a robust network of over 1,400 registered developers using its software developer kit to tightly integrate and enable sophisticated barcode scanning into their applications. Socket Mobile is headquartered in Newark, Calif. and can be reached at +1-510-933-3000 or www.socketmobile.com. Follow Socket Mobile on Facebook, Twitter @socketmobile or subscribe to sockettalk, the company's official blog.
Investor Relations Contact:
Socket Investor Contact:
Todd Kehrli / Jim Byers
Dave Dunlap
MKR Group, Inc.
Chief Financial Officer
323-468-2300
510-933-3035
sckt@mkr-group.com
dave@socketmobile.com
Socket and SoMo are registered trademarks of Socket Mobile. All other trademarks and trade names contained herein may be those of their respective owners.
© 2015, Socket Mobile, Inc. All rights reserved.
TNXP - sold here around 8.85 for a 17%
profit. Wanted a bounce and got it.
OML.v - Omni-Lite Industries Reports Strong Six Month and Second Quarter Results
PR Newswire Omni-Lite Industries Canada Inc.
- Six Month Revenues Up 26%
- Cash Flow from Operations Up 49% Over Six Months
- Six Month Adjusted EBITDA(1) Up 48%
- Second Quarter Gross Margin of 60.2%, a 250 Basis Point Increase
https://finance.yahoo.com/news/omni-lite-industries-reports-strong-123000759.html
CERRITOS, CA, July 20, 2015 /CNW/ - For the six months ended June 30, 2015 Omni-Lite Industries Canada Inc. (the "Company") (OML.V) (OLNCF) is pleased to report revenue of $4,014,631 US and cash flow from operations(1) of $1,354,823 US. Over the same period last year, revenue and cash flow from operations were up 26 percent and 49 percent respectively. Adjusted EBITDA(1) over the six month period was $1,344,507 US, an increase of 48 percent over the prior period. Net income was $879,894 US, an increase of 189 percent from the prior period. In 2015 gross margin increased to 59.3 percent from 58.5 percent in the same period last year. Earnings per share in the six month period were $0.08 compared to $0.03 in the prior period. This represents a 200 percent increase year over year.
SUMMARY OF SIX MONTH FINANCIAL HIGHLIGHTS (US $)
Basic Weighted Average Shares
Issued And Outstanding:
11,697,346
For the period
ended June 30,
2015
For the period
ended June 30,
2014
%
Increase
Revenue
$4,014,631
$3,182,790
26%
Cash flow from operations(2)
1,354,823
911,548
49%
Adjusted EBITDA(2)
1,344,507
886,929
48%
Net Income
879,894
305,000
188%
EPS ($US)
0.08
0.03
200%
Revenue in the three month period ended June 30, 2015 was $2,241,296 US, an increase of 24% over the same period in 2014 and the second best June quarter in the Company's history. Cash flow from operations(1) over the same period was $829,469 US an increase of 55% over the same period in 2014. Adjusted EBITDA(1) over the period was $831,276 US, an increase of 56%. Net income in the second quarter was $567,581 US, an increase of 116% over 2014. Earnings per share in Q2 2015 were $0.05 US. Earnings per share increased 122% in the second quarter of 2015 over the second quarter of 2014 and gross margin increased to 60.2 percent, a 250 basis point increase.
SUMMARY OF THREE MONTH FINANCIAL HIGHLIGHTS (US $)
Basic Weighted Average
Shares Issued And
Outstanding: 11,787,625
For the period
ended June 30,
2015
For the period
ended June 30,
2014
%
Increase
Revenue
$2,241,296
$1,809,465
24%
Cash flow from operations(1)
829,469
535,912
55%
Adjusted EBITDA(1)
831,276
531,684
56%
Net Income
567,581
262,401
116%
EPS ($US)
$0.05
$0.02
122%
"The improved revenues, gross margins, cash flow, Adjusted EBITDA(1), net income, and earnings per share measured in the first two quarters of 2015 were the result of the Company's continued strong growth in the Military, Aerospace, and Specialty Automotive divisions," stated David F. Grant, CEO, "The sophistication of the new seven die progressive cold forging system arriving in the third quarter of this year will be critical to the Company's engineering success as its unique capabilities will contribute to several key projects currently underway or planned for the near future."
Quarterly Information
The following table summarizes the Company's financial performance over the last eight quarters.
Jun
30/2015
Mar
31/2015
Dec
31/2014
Sep
30/2014
Jun
30/2014
Mar
31/2014
Dec
31/2013
Sep
30/2013
Revenue
2,241,296
1,773,335
1,038,770
1,628,758
1,809,465
1,373,325
1,182,752
1,667,030
Cash flow from
operations(1)
829,469
525,354
(104,004)
462,181
535,912
375,636
53,130
512,102
Adjusted EBITDA(1)
831,276
513,231
(93,019)
461,223
531,684
355,245
113,723
457,242
Net income (loss)
567,581
312,313
(80,467)
244,750
262,401
42,599
(254,297)
316,596
E(L)PS - basic (US)
.048
.027
(.007)
.021
.022
.003
(.021)
.026
ALL FIGURES IN US DOLLARS UNLESS NOTED
(1) Cash flow from operations is a non-GAAP term requested by the oil and gas investment community that represents net earnings adjusted for non-cash items including depreciation, depletion and amortization, future income taxes, asset write-downs and gains (losses) on sale of assets, if any. Adjusted EBITDA is a non-GAAP financial measure defined as earnings before interest, taxes, depreciation, amortization, stock-based compensation provision, gains (losses) on sale of assets, if any. These are non-GAAP financial measures, as defined herein, and should be read in conjunction with GAAP financial measures. These non-GAAP financial measures are not presented as an alternative to GAAP cash flows from operations, as a measure of our liquidity or as an alternative to reported net income as an indicator of our operating performance. The non-GAAP financial measures as used herein may not be comparable to similarly titled measures reported by other companies. We believe the use of Adjusted EBITDA and non-GAAP cash flow from continuing operations along with GAAP financial measures enhances the understanding of our operating results and may be useful to investors in comparing our operating performance with that of other companies and estimating our enterprise value. Adjusted EBITDA is also a useful tool in evaluating the operating results of the Company given the significant variation that can result from, for example, the timing of capital expenditures and the amount of working capital in support of our programs and contracts. We also use Adjusted EBITDA internally to evaluate the operating performance of the Company, to allocate resources and capital, and to evaluate future growth opportunities.
Please see www.sedar.com or contact the Company for complete results.
Omni-Lite Industries Canada Inc. is a rapidly growing high technology company that develops and manufactures precision components utilized by Fortune 500 companies including Boeing, Airbus, Bombardier, Embraer, Alcoa, Ford, Borg Warner, Chrysler, the U.S. Military, Nike, and adidas.
Except for historical information contained herein this document contains forward-looking statements. These statements contain known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Finjan Files Second Lawsuit Against Blue Coat -- Asserting Additional Finjan Patents Against New Infringing Blue Coat Products and Services
Marketwired Finjan Holdings, Inc.
EAST PALO ALTO, CA--(Marketwired - Jul 16, 2015) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, today announced that its subsidiary, Finjan, Inc. (Finjan) has filed a second patent infringement lawsuit against Blue Coat Systems, Inc. (Blue Coat), alleging infringement of seven Finjan patents relating to new infringing Blue Coat products and services.
The Complaint (5:15-cv-03295, Docket No. 1), filed July 15, 2015, in the U.S. District Court for the Northern District of California, alleges that Blue Coat's new products and services infringe seven Finjan patents. In particular, Finjan is asserting infringement of U.S. Patent Nos. 6,154,844; 6,965,968; 7,418,731; 8,079,086; 8,225,408; 8,566,580; 8,677,494; four of which are being asserted against Blue Coat for the first time.
Finjan is seeking a jury trial; entry of judgment of direct and indirect infringement of certain claims of each of the asserted patents by Blue Coat; preliminary and permanent injunction against Blue Coat and its officers, among others, from infringing the asserted patents; and damages to be determined by a jury.
"We remain committed to protecting the value of Finjan's patented technologies for our shareholders and existing licensees to our growing portfolio," stated Phil Hartstein, Finjan's President and CEO. "Blue Coat continues to launch new products and services, and more recently has had an ownership change representing a potential catalyst to accelerate their use of the technology. This most recent filing is intended to preserve our case as we pursue fair value in a license with Blue Coat."
This original case against Blue Coat (CAND-13-cv-03999-BLF) will be proceeding to trial on July 20, 2015, with all six patents included in Finjan's first complaint against Blue Coat. Those patents include 6,804,780; 6,154,844; 7,418,731; 6,965,968; 7,058,822 and 7,647,633. The trial in the first case is expected to last for two weeks.
Finjan has filed patent infringement lawsuits against FireEye, Proofpoint, Sophos, Symantec, and Palo Alto Networks relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
http://finance.yahoo.com/news/finjan-files-second-lawsuit-against-123100353.html
ESCC - added @.54. As long as shares are available
at this price, i am buying.
TNXP - bought @7.55. The stock is down from
10.5 to 7.5 and stochastics are in
a buying zone. Should be at least good for a bounce.
Finjan Provides Litigation Update in Blue Coat Case
Trial Set to Begin July 20, 2015
Marketwired Finjan Holdings, Inc.
EAST PALO ALTO, CA--(Marketwired - Jul 14, 2015) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, is providing a litigation update in its case against Blue Coat Systems, Inc. (CAND-13-cv-03999-BLF). Pre-trial conference was completed July 2, 2015 and the case will proceed to trial, as planned July 20, 2015, with all six patents against accused infringing Blue Coat products and services. The trial is expected to last for two weeks.
A Pre-trial conference was held before the Honorable Beth Labson-Freeman on July 2, 2015. Pre-trial motions, specifically, motions in limine, which request the Court to exclude certain evidence at trial, were heard on July 2, 2015.
On July 6, 2015, the Court heard the parties' motions to exclude certain expert testimony, a specialized motion in limine also known as Daubert Motions. Generally, Daubert Motions request courts to exclude testimony of a purported expert on the grounds that the witness either does not possess the requisite level of expertise, or used unreliable data, methods, or principles in arriving at their opinion.
On July 8, 2015, Judge Freeman's Order on the parties' Motions in limine and Pre-trial Orders was entered (Docket No. 367). The Order on the parties' Daubert Motions is pending with the Court and might not be entered until after the trial begins. There are no remaining motions to be heard outside of the trial.
Finjan has filed patent infringement lawsuits against FireEye, Proofpoint, Sophos, Symantec, and Palo Alto Networks relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
ABOUT FINJAN
Founded in 1997, Finjan is recognized globally as a cybersecurity pioneer and leader. Finjan's investment in innovation is captured in its patent portfolio, centered around software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan's software detects malicious code and protects end users from identity and data theft, spyware, malware, phishing, trojans, and other online threats. To date, Finjan has successfully licensed its intellectual property to major technology companies for more than $150 million. For more information about Finjan, please visit www.finjan.com.
http://finance.yahoo.com/news/finjan-provides-litigation-blue-coat-113100974.html
FNJN (1.43) - up 7% with big volume. FireEye (FEYE) is
an $8 billion company.
Finjan Succeeds in Invalidating Majority of Claims of Two FireEye Cybersecurity Patents
Marketwired Finjan Holdings, Inc.
EAST PALO ALTO, CA--(Marketwired - Jul 13, 2015) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, announced that the Patent Trial and Appeals Board (PTAB) at the US Patent and Trademark Office (USPTO) granted Finjan's petitions for Inter Partes Review (IPR) of two FireEye (NASDAQ: FEYE) patents and subsequently determined that a majority of claims in US Patent Nos. 8,171,533 and 8,291,499, are invalid. Notification of the final decision on both IPR's was received July 10, 2015.
"Finjan challenged the validity of FireEye's '533 and '499 patents because we believed FireEye was not the first to invent the claimed technologies," stated Phil Hartstein, President and CEO of Finjan Holdings, Inc. "The PTAB's determinations confirmed this belief."
Final Decisions:
Case number PTAB-IPR2014-00344, filed January 14, 2014. With respect to FireEye's U.S. Patent No. 8,291,499 (Aziz, Final decision in Docket 39 dated July 10, 2015), Claims 1-4, 6-8, 19, 20, 22-25, 27-29, representing 16 of 30 claims in the patent, were cancelled.
Case number PTAB-IPR2014-00492, filed March 7, 2014. With respect to FireEye's Patent No. 8,171,553 (Aziz, Final decision in Docket 29 dated July 10, 2015), Claims 1, 3-7, 12-14, 16, 18, 20, 22-30, representing 20 of 30 claims in the patent, were cancelled.
Finjan has filed patent infringement lawsuits against FireEye, Blue Coat, Proofpoint, Sophos, Symantec, and Palo Alto Networks relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
ABOUT FINJAN
Founded in 1997, Finjan is recognized globally as a cybersecurity pioneer and leader. Finjan's investment in innovation is captured in its patent portfolio, centered around software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan's software detects malicious code and protects end users from identity and data theft, spyware, malware, phishing, trojans, and other online threats. To date, Finjan has successfully licensed its intellectual property to major technology companies for more than $150 million. For more information about Finjan, please visit www.finjan.com.
http://finance.yahoo.com/news/finjan-succeeds-invalidating-majority-claims-120000521.html
Finjan Succeeds in Invalidating Majority of Claims of Two FireEye Cybersecurity Patents
Marketwired Finjan Holdings, Inc.
EAST PALO ALTO, CA--(Marketwired - Jul 13, 2015) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, announced that the Patent Trial and Appeals Board (PTAB) at the US Patent and Trademark Office (USPTO) granted Finjan's petitions for Inter Partes Review (IPR) of two FireEye (NASDAQ: FEYE) patents and subsequently determined that a majority of claims in US Patent Nos. 8,171,533 and 8,291,499, are invalid. Notification of the final decision on both IPR's was received July 10, 2015.
"Finjan challenged the validity of FireEye's '533 and '499 patents because we believed FireEye was not the first to invent the claimed technologies," stated Phil Hartstein, President and CEO of Finjan Holdings, Inc. "The PTAB's determinations confirmed this belief."
Final Decisions:
Case number PTAB-IPR2014-00344, filed January 14, 2014. With respect to FireEye's U.S. Patent No. 8,291,499 (Aziz, Final decision in Docket 39 dated July 10, 2015), Claims 1-4, 6-8, 19, 20, 22-25, 27-29, representing 16 of 30 claims in the patent, were cancelled.
Case number PTAB-IPR2014-00492, filed March 7, 2014. With respect to FireEye's Patent No. 8,171,553 (Aziz, Final decision in Docket 29 dated July 10, 2015), Claims 1, 3-7, 12-14, 16, 18, 20, 22-30, representing 20 of 30 claims in the patent, were cancelled.
Finjan has filed patent infringement lawsuits against FireEye, Blue Coat, Proofpoint, Sophos, Symantec, and Palo Alto Networks relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
ABOUT FINJAN
Founded in 1997, Finjan is recognized globally as a cybersecurity pioneer and leader. Finjan's investment in innovation is captured in its patent portfolio, centered around software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan's software detects malicious code and protects end users from identity and data theft, spyware, malware, phishing, trojans, and other online threats. To date, Finjan has successfully licensed its intellectual property to major technology companies for more than $150 million. For more information about Finjan, please visit www.finjan.com.
http://finance.yahoo.com/news/finjan-succeeds-invalidating-majority-claims-120000521.html
KINS - Kingstone Companies Announces Signing of New Reinsurance Treaties
Business Wire Kingstone Companies, Inc.
KINGSTON, N.Y.--(BUSINESS WIRE)--
Kingstone Companies, Inc. (Nasdaq CM: KINS) (the “Company” or “Kingstone”), a multi-line regional property and casualty insurance holding company, today announced that the Company’s wholly-owned subsidiary, Kingstone Insurance Company, entered into various reinsurance agreements with multiple reinsurers for the treaty year beginning July 1, 2015. The new agreements include improved coverage terms providing for better downside protection, increased coverage, and a significant reduction in exposure-adjusted reinsurance costs. The new treaties are highlighted by the following features:
Catastrophe Reinsurance Treaty
$176 million in coverage was purchased from a panel of 34 individual reinsurers. This is an increase from the $137 million purchased in the expired term, of which $54 million was included in the quota share treaty. After the $4 million direct retention (of which our net share is $2.4 million), the Company is now covered for up to a $180 million ground-up loss event.
The Company obtained a 10.3% exposure-adjusted rate reduction compared to the corresponding premium paid for catastrophe coverage on the expired treaty.
The Company purchased Reinstatement Premium Protection on the first $16 million layer of catastrophe coverage above the $4 million direct retention. This coverage was not purchased in prior years, and protects the Company from additional premium charges in the event of a catastrophe event. Such an event is more likely this year than in the expiring treaty due to additional growth and the fact that the $4 million direct retention remained unchanged.
As in the expired treaty, the Company has purchased coverage protecting up to a 1-in-145 year event, based on blended expected outcomes from two commonly used catastrophe models.
The Company’s maximum pre-tax retained loss in a catastrophe event increased from $1,800,000 to $2,400,000. This is due to the increase in net loss retention after quota share reinsurance from 45% to 60%.
The new treaty includes the same terms for the winter storm aggregate cover as in the expired treaty. Aggregate winter losses exceeding $4 million over any consecutive 28 day period attach to the treaty and are included as a single catastrophe occurrence.
The hours clause has been expanded to 120 hours, up from the 96 hours included in the expired treaty.
Personal Lines Quota Share Treaty
The Company has reduced its ceding percentage from 55% to 40%, as planned.
The new treaty is on a “net” of catastrophe reinsurance basis, as opposed to the “gross” arrangement that existed in prior years. Under a “net” arrangement, all catastrophe reinsurance coverage is now purchased directly by the Company (see below).
The new structure drastically reduces the adverse impact that a catastrophic event can have on ceding commissions, while improving the minimum commissions to be earned on the ceded premiums.
In most scenarios, the Company expects to earn more under the new “net” treaty terms as compared to the expiring “gross” treaty terms. Specifically, the benefit of the new “net” terms compared to the expiring “gross” terms increases under higher loss ratio scenarios or if a catastrophe event occurs.
Maiden Re and Swiss Re continue as treaty participants, each with a 50% share of the treaty
Per-risk Excess of Loss Treaties
The maximum retention on any one policy loss (pre-tax) changed as follows:
Personal lines- $450,000 up from $360,000 in prior term
Commercial lines- $425,000 up from $400,000 in prior term
Commercial auto- $300,000 remains as in prior term
Total protection up to a $4.5 million single loss, up from $4 million in the prior treaty, and covering the maximum policy limits currently offered by the Company.
Mr. Victor Brodsky, Chief Financial Officer of Kingstone, noted, “The new net quota share arrangement and reduced ceding percentage continues the Company’s strategy to retain more of our profitable personal lines business. The net structure also provides us with a greater benefit in higher loss scenarios than the previous gross structure, resulting in a smaller downside range than existed under the previous arrangement.”
Mr. Benjamin Walden, SVP and Chief Actuary, commented, “We are very pleased with the coverage and terms we were able to obtain for catastrophe reinsurance in the new treaty. Due to continued favorable reinsurance pricing conditions, we were able to achieve the same protection for a 1-in-145 year event at a significantly lower cost on an exposure-adjusted basis. With our net retention at $2.4 million and purchasing reinstatement premium protection for our first layer up to a $20 million direct loss, we are much better protected against catastrophe events. We were able to improve coverage terms, and again receive coverage for winter storm losses in any consecutive 28 day period.”
Mr. Barry Goldstein, Chairman and CEO of Kingstone, stated, “For this renewal, we set out two major goals. First, to continue to reduce Kingstone’s reliance on quota share reinsurance. We are well on our way. In spite of our substantial growth in written premiums, we have reduced the percentage ceded from 75% to 40% over the past two years while maintaining our self-imposed leverage limitation. Our second goal was to leverage current market conditions to reduce our downside risk, particularly in the event of a major weather event, such as Superstorm Sandy. We were able to do so under the Net treaty concept which includes an increase to the minimum ceding commission to be received on the quota share portion. This renewal demonstrates the importance of our relationships with those in the reinsurance community and the belief that these reinsurers have in Kingstone’s long term performance, both financially and operationally. Maintaining strong working relationships with our reinsurance partners through our long term intermediary continues to be a top priority for the Company.”
About Kingstone Companies, Inc.
Kingstone is a property and casualty insurance holding company whose principal operating subsidiary, Kingstone Insurance Company, is domiciled in the State of New York. Kingstone is a multi-line regional property and casualty insurance company writing business exclusively through independent retail and wholesale agents and brokers. Kingstone is licensed to write insurance policies in New York and Pennsylvania. Kingstone offers property and casualty insurance products to individuals and small businesses primarily in New York State.
http://finance.yahoo.com/news/kingstone-companies-announces-signing-reinsurance-123000184.html
KINS - Kingstone Companies Announces Signing of New Reinsurance Treaties
Business Wire Kingstone Companies, Inc.
KINGSTON, N.Y.--(BUSINESS WIRE)--
Kingstone Companies, Inc. (Nasdaq CM: KINS) (the “Company” or “Kingstone”), a multi-line regional property and casualty insurance holding company, today announced that the Company’s wholly-owned subsidiary, Kingstone Insurance Company, entered into various reinsurance agreements with multiple reinsurers for the treaty year beginning July 1, 2015. The new agreements include improved coverage terms providing for better downside protection, increased coverage, and a significant reduction in exposure-adjusted reinsurance costs. The new treaties are highlighted by the following features:
Catastrophe Reinsurance Treaty
$176 million in coverage was purchased from a panel of 34 individual reinsurers. This is an increase from the $137 million purchased in the expired term, of which $54 million was included in the quota share treaty. After the $4 million direct retention (of which our net share is $2.4 million), the Company is now covered for up to a $180 million ground-up loss event.
The Company obtained a 10.3% exposure-adjusted rate reduction compared to the corresponding premium paid for catastrophe coverage on the expired treaty.
The Company purchased Reinstatement Premium Protection on the first $16 million layer of catastrophe coverage above the $4 million direct retention. This coverage was not purchased in prior years, and protects the Company from additional premium charges in the event of a catastrophe event. Such an event is more likely this year than in the expiring treaty due to additional growth and the fact that the $4 million direct retention remained unchanged.
As in the expired treaty, the Company has purchased coverage protecting up to a 1-in-145 year event, based on blended expected outcomes from two commonly used catastrophe models.
The Company’s maximum pre-tax retained loss in a catastrophe event increased from $1,800,000 to $2,400,000. This is due to the increase in net loss retention after quota share reinsurance from 45% to 60%.
The new treaty includes the same terms for the winter storm aggregate cover as in the expired treaty. Aggregate winter losses exceeding $4 million over any consecutive 28 day period attach to the treaty and are included as a single catastrophe occurrence.
The hours clause has been expanded to 120 hours, up from the 96 hours included in the expired treaty.
Personal Lines Quota Share Treaty
The Company has reduced its ceding percentage from 55% to 40%, as planned.
The new treaty is on a “net” of catastrophe reinsurance basis, as opposed to the “gross” arrangement that existed in prior years. Under a “net” arrangement, all catastrophe reinsurance coverage is now purchased directly by the Company (see below).
The new structure drastically reduces the adverse impact that a catastrophic event can have on ceding commissions, while improving the minimum commissions to be earned on the ceded premiums.
In most scenarios, the Company expects to earn more under the new “net” treaty terms as compared to the expiring “gross” treaty terms. Specifically, the benefit of the new “net” terms compared to the expiring “gross” terms increases under higher loss ratio scenarios or if a catastrophe event occurs.
Maiden Re and Swiss Re continue as treaty participants, each with a 50% share of the treaty
Per-risk Excess of Loss Treaties
The maximum retention on any one policy loss (pre-tax) changed as follows:
Personal lines- $450,000 up from $360,000 in prior term
Commercial lines- $425,000 up from $400,000 in prior term
Commercial auto- $300,000 remains as in prior term
Total protection up to a $4.5 million single loss, up from $4 million in the prior treaty, and covering the maximum policy limits currently offered by the Company.
Mr. Victor Brodsky, Chief Financial Officer of Kingstone, noted, “The new net quota share arrangement and reduced ceding percentage continues the Company’s strategy to retain more of our profitable personal lines business. The net structure also provides us with a greater benefit in higher loss scenarios than the previous gross structure, resulting in a smaller downside range than existed under the previous arrangement.”
Mr. Benjamin Walden, SVP and Chief Actuary, commented, “We are very pleased with the coverage and terms we were able to obtain for catastrophe reinsurance in the new treaty. Due to continued favorable reinsurance pricing conditions, we were able to achieve the same protection for a 1-in-145 year event at a significantly lower cost on an exposure-adjusted basis. With our net retention at $2.4 million and purchasing reinstatement premium protection for our first layer up to a $20 million direct loss, we are much better protected against catastrophe events. We were able to improve coverage terms, and again receive coverage for winter storm losses in any consecutive 28 day period.”
Mr. Barry Goldstein, Chairman and CEO of Kingstone, stated, “For this renewal, we set out two major goals. First, to continue to reduce Kingstone’s reliance on quota share reinsurance. We are well on our way. In spite of our substantial growth in written premiums, we have reduced the percentage ceded from 75% to 40% over the past two years while maintaining our self-imposed leverage limitation. Our second goal was to leverage current market conditions to reduce our downside risk, particularly in the event of a major weather event, such as Superstorm Sandy. We were able to do so under the Net treaty concept which includes an increase to the minimum ceding commission to be received on the quota share portion. This renewal demonstrates the importance of our relationships with those in the reinsurance community and the belief that these reinsurers have in Kingstone’s long term performance, both financially and operationally. Maintaining strong working relationships with our reinsurance partners through our long term intermediary continues to be a top priority for the Company.”
About Kingstone Companies, Inc.
Kingstone is a property and casualty insurance holding company whose principal operating subsidiary, Kingstone Insurance Company, is domiciled in the State of New York. Kingstone is a multi-line regional property and casualty insurance company writing business exclusively through independent retail and wholesale agents and brokers. Kingstone is licensed to write insurance policies in New York and Pennsylvania. Kingstone offers property and casualty insurance products to individuals and small businesses primarily in New York State.
http://finance.yahoo.com/news/kingstone-companies-announces-signing-reinsurance-123000184.html
Grand Perfecta Provides 2015 Third Quarter Update to Stockholders
Accesswire
TOKYO, JAPAN / ACCESSWIRE / July 3, 2015 / GRAND PERFECTA, INC. (GPIW) is pleased to provide this update for its stockholders on your company's progress and operations.
We have recently completed the process of becoming a fully-reporting, public company, which we believe will enhance our profile and reputation, and make current information about the company readily available to our stockholders and the public markets.
Grand Perfecta is one of the largest horse racing information companies serving the Japanese market. Grand Perfecta Group delivers horse racing information mainly through its branded websites as typified by Umajin.net, a comprehensive source of information related to horse racing. The group shares its content with over 1.2 million users, and has a steady user base of paid customers who rely on its content for information on races and tracks throughout Japan and in Hong Kong. Japan is currently the largest market for horse race wagering globally, with wagers exceeding $28 billion annually generated by over 8 million racing fans.
Our unaudited net sales for the three months ended April 30, 2015 were $4.3 million, down approximately $576,000 from the comparable period in 2014. For the nine months ended April 30, 2015, our unaudited net sales were $13.8 million, versus revenues of $16.7 million for the comparable period in 2014. These declines are due mainly to the stronger US dollar to the Japanese yen, and an increase in the consumption tax rate from 5% to 8% starting in April 2014.
We have been very focused on utilizing our excess free cash flow to pay down debt, so our current portion of notes payable decreased from $8.3 million at July 31, 2014, to $3.2 million at April 30, 2015, and total liabilities decreased from $13.8 million at July 31, 2014, to $11.1 million at April 30, 2015. Not only will this allow us to bring more net income to the Company, but it also allows us to re-allocate some of our cash flows towards new growth initiatives and other strategic expenditures which we hope will lead to the increase of shareholder value.
While we are seeking opportunities to make acquisitions in the space, and we are also focused on finding an opportunity to enter the fantasy sports sector, which is a large and growing Internet user market. Our 30+ year track record in the horse racing sector in Japan leaves us ideally suited to enter this market.
We will continue to update our shareholders on the Company's activities as they develop. Management is appreciative of your continued support.
Sincerely,
SHUYA WATANABE
Chairman & Chief Executive Officer
About Grand Perfecta, Inc.
Grand Perfecta, Inc., ("GPIW") a Nevada corporation, is engaged in the business of publishing and disseminating horse racing information and other content related to horse racing in Japan and the Japanese horse racing industry through various types of media, including numerous websites and printed materials. Horse racing in Japan is a popular equestrian sport with approximately 16,000 horse races held each year, which are predominately flat and jump races. Horse racing is organized and managed by the Japan Racing Association (JRA) and National Association of Racing (NAR), both of which are subject to the supervision of the Ministry of Agriculture, Forestry and Fisheries. This system of government supervision and administration of horse racing is unique to Japan and, we believe, one of the main reasons horse racing in Japan is considered by many the best in the world.
http://finance.yahoo.com/news/grand-perfecta-provides-2015-third-195500276.html
ESCC - bought more @.55. The stock is almost
oversold with RSI @32 and stochastics in a buying zone.
In the last few days it seems like someone wants
to liquidate a position so this is an opportunity IMO.
ESCC (0.58) - bought it back here. They are
a much stronger company now after the pension
settlement (removing around $40M in pension liabilities in
exchange for payments totaling $10.5M over twelve years).
They have a huge backlog ($34 million).
Also, even after the initial $1.5M payment to the PBGC,
cash per share will be about $.50.
On April 21, 2015, Evans & Sutherland Computer Corporation (the "Company") and its wholly owned subsidiary Spitz, Inc. ("Spitz" and together with the Company, the "Obligors") entered into a settlement agreement (the "Settlement Agreement") with the Pension Benefit Guaranty Corporation (the "PBGC") to settle previously disclosed liabilities (the "ERISA Liabilities") of the Obligors under the Employee Retirement Income Security Act of 1974, as amended ("ERISA"), and all other liabilities of the Obligors relating to the Evans & Sutherland Computer Corporation Pension Plan (the "Plan") (except for those resulting from any violation of Part 4 of Subtitle B of Title 1 of ERISA) (the "Settled ERISA Liabilities").
Pursuant to the Settlement Agreement, the Obligors agreed to (a) pay to the PBGC a total of $10.5 million, with $1.5 million due within ten days following the effective date of the Settlement Agreement and the remainder paid in twelve annual installments of $750 thousand beginning on October 31, 2015 (the "Installments") and (b) issue within ten days following the effective date of the Settlement Agreement 88,117 shares of the Company's treasury stock in the name of the PBGC.
In connection with the Settlement Agreement, on April 21, 2015, the Company, as the administrator of the Plan, and the PBGC entered into an Agreement For Appointment of Trustee and Termination of Plan (the "Termination Agreement") (a) terminating the Plan, (b) establishing March 8, 2013 as the Plan's termination date and (c) appointing the PBGC as statutory trustee of the Plan.
To secure the Obligors obligations under the Settlement Agreement, on April 21, 2015 the Obligors entered into a Security Agreement with the PBGC (the "Security Agreement") granting to the PBGC a security interest on all of the Obligors' presently owned and after-acquired personal property and proceeds thereof, free and clear of all liens and other encumbrances, except those described therein, and Spitz executed an Open-End Mortgage, Security Agreement, Assignment of Leases and Rents and Fixture Filing in favor of the PBGC (the "Mortgage") on certain real property owned by Spitz and described therein. The Settlement Agreement also requires that the PBGC withdraw all lien notices with respect to the statutory liens it previously perfected on behalf of the Plan with respect to all real and personal property of the Obligors as soon as reasonably practicable after the 91st day after the perfection of all consensual liens granted to the PBGC by the Security Agreement and Mortgage.
The Settlement Agreement further provides that on the 91st day after the full payment of all Installments, the PBGC will be deemed to have released the Obligors from the Settled ERISA Liabilities and that the PBGC will not take any action to enforce the Settled ERISA Liabilities for so long as the Obligors are not in default in their obligations under the Settlement Agreement, the Security Agreement or the Mortgage.
The foregoing descriptions of the Settlement Agreement, Termination Agreement, Security Agreement and Mortgage and the transactions contemplated therein are qualified in their entirety by reference to the full text of such agreements and instruments, which are filed herewith as Exhibits 10.1, 10.2, 10.3 and 10.4, respectively, and incorporated herein by reference.
PKT.v - Parkit Announces Results for the Second Quarter of 2015
Marketwired Parkit Enterprise Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 30, 2015) - Parkit Enterprise Inc. ("Parkit") (TSX VENTURE:PKT)(PKTEF) is pleased to announce its financial and operational results for the six month period ended April 30, 2015.
Highlights
On April 22, 2015, announced the formation of a joint venture investment vehicle ("the joint venture") that will seek to acquire and aggregate approximately $500 million in income-producing parking assets.
Sale of Canopy and Expresso parking facilities into the joint venture resulted in gains of $13.4 million and $1.2 million, respectively, after adjusting for minority interests.
Net assets increased to $20.4 million ($0.8 million as at April 30, 2014), reflecting the completion of the joint venture.
Second quarter property revenue of $2.7 million, a 20% increase when compared to the second quarter of 2014.
"I am pleased with Parkit's results for the second quarter, which demonstrate both revenue growth and a focus on cost control," stated Rick Baxter, the Company's Chief Executive Officer. "However, while these results do provide evidence of the quality of the assets, they do not fully capture the scope of our business, which has undergone significant changes since the final week of the second quarter. The joint venture announced on April 22 is a transformative transaction, crystalizing the value of our prior investments and establishing a profitable foundation for our long-term development. While the impact of this transaction is visible on Parkit's balance sheet, which witnessed a $19.6 million increase in our net assets relative to this point last year, the joint venture's benefits have not yet been fully realized in our income statement. I look forward to sharing Parkit's results for the third quarter."
Please refer to Parkit's Interim Financial Statements and Management's Discussion and Analysis at www.sedar.com for detailed financial information and analysis.
ABOUT PARKIT
Parkit Enterprise Inc. is engaged in the acquisition, optimization, and asset management of income-producing parking facilities across the United States.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.
Contact:
Rick Baxter
rick@parkitenterprise.com
(604) 424-8707
Parkit Enterprise Inc.
Suite 1088 - 999 West Hastings Street
Vancouver, British Columbia
Canada V6C 2W2
Web: www.parkitenterprise.com
Twitter: http://twitter.com/parkit_pkt
http://finance.yahoo.com/news/parkit-announces-results-second-quarter-191433542.html
value, yes, BIS is 2x. "The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified."
RXII market cap is not under $20 million but
around $35 million and their Outstanding Shares
are not 36 million but over 60 million.
In the end of May they issued 26 million units at a price to the public of $0.40 per share for gross proceeds of approximately $10.4 million. Each unit consists of (i) one share of common stock, (ii) a 13-month overallotment purchase right to purchase 0.50 of a share of common stock at a price of $0.455 per share and (iii) a five-year warrant to purchase 0.50 of a share of common stock at a price of $0.52 per share.
SVON up 16% to 1.08. There is also a Bristol-Myers
Squibb oncology collaboration that is not mentioned
in the recent presentation but Zen verified with IR
on December that work is ongoing.
zen_lunatic420 • Dec 14, 2014 9:58 PM
Bristol-Myers Squibb oncology collaboration is ongoing
The BIO Investor Forum slide presentation from October had mentioned a collaboration with BMY for two cancer targets, noting that Sevion work was to begin in 2014, so I was a bit concerned when that presentation was recently removed from the company website. I called the IR firm, he got in-touch with the company and came back with his response:
Hi XXXXX. I checked with the Company and the collaboration with BMS for two undisclosed programs targeting oncology is ongoing. No further information has been made available to date. We would expect that the Company will announce any “material” developments regarding this collaboration as they occur.
Please let me know if you have any other questions, and thanks for your interest in Sevion.
Best,
Matthew Haines
Managing Director on almost double the